Malignant Male Reproductive System Neoplasm

Malignant Male Reproductive System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

6,225 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,451
Recruiting: 784
Ph III recruiting: 82
Growth YoY: +24.4%
Industry share: 18%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 27.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (762)

clinicaltrialsPublishedShowing 151–155 of 155 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00024414	DHA-Paclitaxel in Treating Patients With Metastatic Prostate Cancer	unknown	Phase 2	—	TheradexINDUSTRY	1	Jul 24, 2008	clinicaltrials
NCT00405574	Study of ATN-224 in Patients With Prostate Cancer	unknown	Phase 2	50	AttenuonINDUSTRY	1	Jan 30, 2008	clinicaltrials
NCT00188383